Stock listing
BOATS:MRKR Marker Therapeutics, Inc. Stock
US listing (BOATS) of Marker Therapeutics, Inc. · home listing NASDAQ:MRKR
Follow Marker Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:MRKR
$0.901 USD -0.079 (-8.1%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MRKR
- Day range
- $0.880 – $0.970 USDNov 2, 2026
- Volume
- 265,716 sharesNov 2, 2026
- Market cap
- $15.02M USDAt the close on Nov 2, 2026 · price × 16.67M shares outstanding
- 52-week range
- $0.840 – $2.460 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $125,006 USDMedian day 72,225 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MRKR · Home | $0.901 USD | -0.079 (-8.1%) | 265,716 | $0.960 | $0.970 | $0.880 | $0.980 | Close on Nov 2, 2026 |
| Frankfurt:GX1 | €0.755 EUR | +0.095 (+14.4%) | — | €0.755 | €0.755 | €0.755 | €0.660 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:MRKR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.901 | -0.079 | -8.1% | $0.960 | $0.970 | $0.880 | 265,716 | |
| $0.980 | -0.030 | -3.0% | $1.030 | $1.040 | $0.966 | 67,558 | |
| $1.010 | +0.010 | +1.0% | $1.030 | $1.070 | $0.980 | 72,225 | |
| $1.000 | +0.049 | +5.1% | $0.955 | $1.070 | $0.901 | 86,904 | |
| $0.951 | +0.045 | +5.0% | $0.920 | $0.970 | $0.890 | 103,887 | |
| $0.906 | -0.054 | -5.6% | $0.949 | $1.040 | $0.880 | 217,593 | |
| $0.960 | -0.110 | -10.3% | $1.070 | $1.120 | $0.960 | 114,400 | |
| $1.070 | -0.060 | -5.3% | $1.170 | $1.170 | $1.070 | 91,500 | |
| $1.130 | -0.030 | -2.6% | $1.160 | $1.270 | $1.130 | 149,900 | |
| $1.160 | -0.040 | -3.3% | $1.190 | $1.240 | $1.110 | 209,400 | |
| $1.200 | +0.160 | +15.4% | $1.090 | $1.200 | $1.050 | 578,800 | |
| $1.040 | +0.120 | +13.0% | $1.020 | $1.200 | $1.000 | 1,146,100 | |
| $0.920 | +0.030 | +3.4% | $0.960 | $0.960 | $0.880 | 120,200 | |
| $0.890 | -0.030 | -3.3% | $0.920 | $0.950 | $0.890 | 65,800 | |
| $0.920 | -0.090 | -8.9% | $1.030 | $1.030 | $0.910 | 175,200 | |
| $1.010 | +0.040 | +4.1% | $0.980 | $1.030 | $0.980 | 107,800 | |
| $0.970 | +0.020 | +2.1% | $0.930 | $1.000 | $0.930 | 91,200 | |
| $0.950 | -0.090 | -8.7% | $1.040 | $1.050 | $0.950 | 96,900 | |
| $1.040 | +0.030 | +3.0% | $1.030 | $1.060 | $1.030 | 37,500 | |
| $1.010 | -0.050 | -4.7% | $1.070 | $1.070 | $1.000 | 77,100 | |
| $1.060 | +0.010 | +1.0% | $1.080 | $1.090 | $1.050 | 73,500 | |
| $1.050 | 0.000 | 0.0% | $1.060 | $1.080 | $1.020 | 100,300 | |
| $1.050 | -0.020 | -1.9% | $1.080 | $1.090 | $0.980 | 127,500 | |
| $1.070 | -0.030 | -2.7% | $1.120 | $1.140 | $1.070 | 38,400 | |
| $1.100 | -0.030 | -2.7% | $1.140 | $1.160 | $1.080 | 90,900 | |
| $1.130 | -0.020 | -1.7% | $1.120 | $1.150 | $1.070 | 164,300 | |
| $1.150 | -0.040 | -3.4% | $1.220 | $1.220 | $1.150 | 29,600 | |
| $1.190 | -0.050 | -4.0% | $1.260 | $1.310 | $1.150 | 141,600 | |
| $1.240 | +0.020 | +1.6% | $1.240 | $1.270 | $1.230 | 64,900 | |
| $1.220 | +0.020 | +1.7% | $1.180 | $1.240 | $1.180 | 38,700 | |
| $1.200 | +0.020 | +1.7% | $1.180 | $1.220 | $1.180 | 24,200 | |
| $1.180 | 0.000 | 0.0% | $1.190 | $1.230 | $1.170 | 47,300 | |
| $1.180 | +0.040 | +3.5% | $1.130 | $1.230 | $1.130 | 60,600 | |
| $1.140 | -0.030 | -2.6% | $1.170 | $1.180 | $1.130 | 35,900 | |
| $1.170 | 0.000 | 0.0% | $1.170 | $1.230 | $1.150 | 12,000 | |
| $1.170 | +0.020 | +1.7% | $1.160 | $1.230 | $1.160 | 17,400 | |
| $1.150 | -0.050 | -4.2% | $1.200 | $1.250 | $1.100 | 59,400 | |
| $1.200 | -0.010 | -0.8% | $1.210 | $1.230 | $1.180 | 55,500 | |
| $1.210 | -0.070 | -5.5% | $1.290 | $1.290 | $1.210 | 71,200 | |
| $1.280 | +0.100 | +8.5% | $1.190 | $1.390 | $1.190 | 200,300 | |
| $1.180 | -0.060 | -4.8% | $1.250 | $1.310 | $1.180 | 35,300 | |
| $1.240 | -0.010 | -0.8% | $1.240 | $1.310 | $1.220 | 43,400 | |
| $1.250 | -0.050 | -3.8% | $1.250 | $1.330 | $1.240 | 167,600 | |
| $1.300 | -0.030 | -2.3% | $1.310 | $1.340 | $1.260 | 21,000 | |
| $1.330 | -0.040 | -2.9% | $1.370 | $1.410 | $1.310 | 59,500 | |
| $1.370 | -0.090 | -6.2% | $1.500 | $1.500 | $1.350 | 84,800 | |
| $1.460 | +0.010 | +0.7% | $1.450 | $1.500 | $1.400 | 24,500 | |
| $1.450 | -0.070 | -4.6% | $1.520 | $1.590 | $1.450 | 33,800 | |
| $1.520 | +0.020 | +1.3% | $1.500 | $1.600 | $1.480 | 146,700 | |
| $1.500 | +0.110 | +7.9% | $1.440 | $1.530 | $1.410 | 238,000 | |
| $1.390 | +0.170 | +13.9% | $1.250 | $1.440 | $1.250 | 99,400 | |
| $1.220 | -0.070 | -5.4% | $1.280 | $1.320 | $1.190 | 80,600 | |
| $1.290 | +0.140 | +12.2% | $1.190 | $1.360 | $1.160 | 232,200 | |
| $1.150 | -0.010 | -0.9% | $1.160 | $1.180 | $1.150 | 46,100 | |
| $1.160 | +0.020 | +1.8% | $1.180 | $1.200 | $1.140 | 42,900 | |
| $1.140 | +0.030 | +2.7% | $1.140 | $1.160 | $1.120 | 45,600 | |
| $1.110 | -0.050 | -4.3% | $1.150 | $1.160 | $1.110 | 30,000 | |
| $1.160 | +0.040 | +3.6% | $1.100 | $1.200 | $1.090 | 73,100 | |
| $1.120 | -0.030 | -2.6% | $1.130 | $1.150 | $1.090 | 55,600 | |
| $1.150 | +0.030 | +2.7% | $1.100 | $1.150 | $1.100 | 48,600 | |
| $1.120 | 0.000 | 0.0% | $1.140 | $1.140 | $1.110 | 40,100 | |
| $1.120 | -0.020 | -1.8% | $1.150 | $1.250 | $1.120 | 30,400 | |
| $1.140 | -0.090 | -7.3% | $1.230 | $1.270 | $1.100 | 103,100 | |
| $1.230 | +0.010 | +0.8% | $1.240 | $1.290 | $1.230 | 34,000 | |
| $1.220 | +0.090 | +8.0% | $1.160 | $1.310 | $1.160 | 65,400 |
- Ticker
- BOATS:MRKR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 19, 2026
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
Calls
Replays
Marker Therapeutics (NASDAQ:MRKR) Q2 2022 Earnings Call
Wed, Feb 16, 2022 · 5:00 PM ET
Watch Transcript
Latest news
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
Oct 19, 2026
Closed $1.20 (+15.4%) on Oct 19, 2026
Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results
Mar 18, 2026
Closed $1.34 (-1.5%) on Mar 18, 2026
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb 18, 2026
Closed $1.50 (+3.4%) on Feb 18, 2026
Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology
Jan 26, 2026
Closed $1.87 (-11.0%) on Jan 26, 2026
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
Jan 5, 2026
Closed $1.79 (+16.2%) on Jan 5, 2026
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Nov 14, 2025
Closed $0.92 (+3.4%) on Nov 14, 2025
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
Nov 5, 2025
Closed $0.92 (+2.2%) on Nov 5, 2025
Decks
Investor Presentation (November 2025)
Investor deck · 20 slides · November 2025
Investor Presentation (August 2025)
Investor deck · 28 slides · Aug 26, 2025
Investor Presentation (August 2025)
Investor deck · 20 slides · Aug 26, 2025
Investor Presentation (January 2024)
Investor deck · 21 slides · Jan 8, 2024
Marker Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 8 in the last 12 months · 105 in all · newest Oct 19, 2026 · oldest 2019
- Calls
- 1 call with a replay · 1 with a transcript · latest Feb 16, 2022
- Decks
- 12 decks · latest November 2025
Where Marker Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MRKR · Home listing | NASDAQ | United States | USD |
| gettex:GX1 | gettex | Germany | EUR |
| BOATS:MRKR · This page | BOATS | United States | USD |
| Frankfurt:GX1 | Frankfurt | Germany | EUR |
| Munich:GX1 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Marker Therapeutics, Inc.